Delivering Gold Standard Childhood Vaccine Recommendations for Americans
Executive orderSigned 08/10Federal Register 08/14Executive Order 14420Open the original
Summary
President Trump declares Gold Standard Childhood Vaccine Recommendations aligned with peer developed countries, citing an HHS assessment that the United States recommends more childhood vaccines than any peer nation, and directs federal programs to support maximal parental choice.
By industry
- Healthcare & Drug Pricing1 trading day+0.9%p15 stocks5 trading days+0.3%p15 stocks20 trading days+4.9%p15 stocks
“it is hereby declared that the United States recognizes Gold Standard Childhood Vaccine Recommendations”
Day by day after the announcement
| Day | Healthcare & Drug Pricing stocks | S&P 500 |
|---|---|---|
| 26/08/07 | 0.0% | 0.0% |
| 26/08/10 | +0.9% | −0.0% |
| 26/08/11 | +0.6% | −0.3% |
| 26/08/12 | +0.3% | −0.1% |
| 26/08/13 | +0.4% | +0.6% |
| 26/08/14 | +0.7% | +0.4% |
| 26/08/17 | +0.3% | −0.1% |
| 26/08/18 | +1.8% | −0.7% |
| 26/08/19 | +3.9% | −0.4% |
| 26/08/20 | +2.1% | −1.3% |
| 26/08/21 | +3.4% | −0.9% |
| 26/08/24 | +4.0% | −1.2% |
| 26/08/25 | +4.8% | −0.9% |
| 26/08/26 | +4.3% | −0.3% |
| 26/08/27 | +3.0% | −0.4% |
| 26/08/28 | +2.6% | −0.5% |
| 26/08/31 | +2.5% | −0.7% |
| 26/09/01 | +4.3% | −1.4% |
| 26/09/02 | +5.3% | −1.0% |
| 26/09/03 | +5.8% | −0.1% |
| 26/09/04 | +4.5% | −0.4% |
Korean stocks in these industries
- Samsung Biologics 207940
- Celltrion 068270
- SK Biopharmaceuticals 326030
Trades in these industries around the announcement
Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.
- Kevin Hern
Full saleUnitedhealth Group
Full saleUnitedhealth Group
UNH
$15K–$50K
Joint
$15K–$50K
Reported 09/25
Traded 09/10
- Sheldon Whitehouse
Partial saleAmgen
Partial saleAmgen
AMGN
$1K–$15K
Spouse
$1K–$15K
Reported 09/02
Traded 08/12
- Thomas H. Kean Jr.
Partial saleJohnson & Johnson
Partial saleJohnson & Johnson
JNJ
$1K–$15K
Self
$1K–$15K
Reported 09/12
Traded 08/27
- John Boozman
Partial saleJohnson & Johnson
Partial saleJohnson & Johnson
JNJ
$1K–$15K
Joint
$1K–$15K
Reported 09/11
Traded 08/20
- David Taylor
Full saleAmgen
Full saleAmgen
AMGN
$1K–$15K
Self
$1K–$15K
Reported 09/05
Traded 08/26
- David Taylor
Full saleAmgen
Full saleAmgen
AMGN
$1K–$15K
Self
$1K–$15K
Reported 09/05
Traded 08/26
- Maria Salazar
BuyMerck
BuyMerck
MRK
$15K–$50K
Self
$15K–$50K
Reported 09/09
Traded 08/19
- Maria Salazar
BuyMerck
BuyMerck
MRK
$15K–$50K
Self
$15K–$50K
Reported 09/09
Traded 08/19
